Blueprint Medicines is a precision therapy company striving to improve human health. With a focus on genomically defined cancers, rare diseases and cancer immunotherapy, we are developing transformational medicines rooted in our leading expertise in protein kinases, which are proven drivers of disease. Our uniquely targeted, scalable approach empowers the rapid design and development of new treatments and increases the likelihood of clinical success. We have two FDA-approved precision therapies and are currently advancing multiple investigational medicines in clinical development, along with a number of research programs.
Contact:
Andrea Gasperino
Area Business Manager – Southern CA / Hawaii
Mobile: (858) 349-1246
E-mail - agasperino@blueprintmedicines.com
Featured Content
